C07D457/06 - CPC Classification Index

ClassID:

95340 ⎘

C07D457/06 - CPC Classification

Classification description:

Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8 Lysergic acid amides

Sub-classes:

C07D457/08 » in which the amide nitrogen is a member of a heterocyclic ring 3

Recent Application in this class:

20260092060

ISOTOPICALLY ENRICHED ANALOGS OF 2-BROMO-LSD, LSD, ALD-52, AND 1P-LSD

20260062409

Composition and Method for Treating Metabolic Disorders

20260062408

PRODRUGS OF SUBSTITUTED ERGOLINES

20250304573

LYSERGIC ACID DERIVATIVES AND METHODS

20250228778

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

20250109130

ISOTOPICALLY ENRICHED ANALOGS OF 2-BROMO-LSD, LSD, ALD-52, AND 1P-LSD

20240368151

NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS

20240287057

PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED HYDROLYSIS OF BROMOCRIPTINE

20240239789

SALTS OF 2-BROMOLYSERGIC ACID DIETHYLAMIDE

20230286974

Composition and Method for Treating Metabolic Disorders

20230150999

Composition and Method for Treating Metabolic Disorders

20210177758

Platform drug delivery system utilizing crystal engineering and theanine dissolution

20210130344

Composition and method for treating metabolic disorders

20210094946

Composition and method for treating metabolic disorders

20180354940

Process of synthesizing 2-bromo-LSD

20180051019

Composition and method for treating metabolic disorders

20170305898

Composition and Method for Treating Metabolic Disorders

20160237080

Process of synthesizing 2-bromo-LSD

20150307486

Ergoline derivatives as dopamine receptor modulators

20130345253

Cabergoline derivatives

20100152223

Crystal form of cabergoline

20090264456

Compostions and methods for preventing and/or treating disorders associated with cephalic pain

20090018127

Ergoline derivatives

20070293677

Process for the preparation of cabergoline

20070122859

Immunoassay for LSD and 2-oxo-3-hydroxy-LSD

20060287350

Process for making cabergoline

20060281777

Process for preparing crystalline form I of cabergoline

20060223998

Synthetic LSD metabolite for preparing haptens used in an LSD metabolite immunoassay

20060217555

Preparation of cabergoline

20060217408

Preparation of cabergoline

20050245560

Preparation of cabergoline

20050158240

Method for labeling with tritium

20050085499

Polymorphs of cabergoline